Oncoc4, Inc.
Clinical trials sponsored by Oncoc4, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for tough prostate cancer: immunotherapy meets targeted radiation Results expected Nov 2026 (estimated)
- New antibody aims to preserve immune checkpoint while fighting cancer Results expected Dec 2026 (estimated)
- New Dual-Action antibody takes on advanced cancers Results expected Jun 2027 (estimated)
- New antibody drug takes aim at Hard-to-Treat cancers Results expected Aug 2027 (estimated)
- New hope for lung cancer patients: experimental drug aims to extend life after other treatments fail Results expected Aug 2027 (estimated)
-
New antibody drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called ONC-783 in 20 people with advanced solid tumors, including colorectal, ovarian, pancreatic, or breast cancer. The drug is a bispecific antibody designed to help the immune system attack cancer cells. The main goal is to find a safe d…
Phase 1 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New Dual-Action antibody takes on advanced cancers
Disease control Recruiting nowThis study tests a new drug called AI-081 in people with advanced solid tumors that have spread or cannot be removed by surgery. The drug is a bispecific antibody that targets two proteins (PD-1 and VEGF) involved in cancer growth and immune evasion. The trial has two phases: fir…
Phase 1/2 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New cancer antibody ONC-841 enters human trials
Disease control Recruiting nowThis early-stage trial tests a new drug called ONC-841 in people with advanced solid tumors that have spread. The drug is an antibody designed to help the immune system attack cancer cells. The study will first find a safe dose, then test it alone and with standard treatments for…
Phase 1 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC